News

Bionova Welcomes Carolina Valoyes and George Scott to Leadership Team

Carolina Valoyes

Carolina Valoyes

George Scott

George Scott

Fremont, CA   February 28, 2024 – Bionova Scientific, an Asahi Kasei Group company and full-service biologics CDMO, today announced the addition of Carolina Valoyes as Senior Vice President of Quality & Compliance and George Scott as Vice President of Facilities & Engineering.

Darren Head, CEO of Bionova, said, “We are so excited to have Carolina and George join our team. Both are seasoned leaders with extensive records of success in the industry. Their presence is already being felt as they add depth and valuable experience to our leadership team.”

Bionova’s Chief Operating Officer, James Glover added, “The addition of Carolina and George significantly strengthens our leadership team and is another important step in raising the bar as we execute on our strategic growth initiatives. Importantly, this enhances our focus on creating an even stronger quality culture here at Bionova. With our strategic focus on commercial readiness in 2024, their experience and leadership will be paramount.”

Carolina Valoyes is an accomplished international leader with more than 20 years of experience in biotechnology, pharmaceuticals and diagnostics operations. She has held various leadership roles and has a proven track record of success in managing manufacturing and quality teams in both clinical and commercial settings. Prior to joining Bionova, Carolina served as the Head of Global Quality Systems at Boehringer Ingelheim (Germany), where she was responsible for defining and deploying Boehringer Ingelheim’s Quality Management Systems strategy. Previously, she held leadership positions in Quality and Manufacturing organizations at Gilead, Novartis, Amgen and Bayer.

George Scott comes to Bionova with 25+ years of experience in the biopharmaceutical and cell therapy manufacturing industry. He has held significant leadership roles in facilities, plant engineering, qualification, automation, capital projects, and technical compliance at Bayer, Abgenix, Amgen, Boehringer-Ingelheim and Allogene. George’s experience includes bringing manufacturing plants from greenfield construction, through PAI and commercial launch.

Please submit any questions regarding this news item using the form below…